{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:09:18Z","timestamp":1779890958292,"version":"3.53.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transcatheter aortic valve implantation (TAVI) outcomes using balloon-expandable valves (BEV) and self-expanding valves (SEV) differ owing to device-specific technical features and anatomical factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to evaluate prospective TAVI device selection based on anatomic features to optimise outcomes compared with published randomised data using two newer-generation devices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 607 consecutive patients with severe aortic stenosis treated at a single centre from 2020 to 2023 underwent TAVI using a prospective device selection strategy. Heavy and\/or asymmetric valve calcification and bicuspid anatomy were preferentially treated with SAPIEN 3\/SAPIEN 3 ULTRA BEV, whereas small annulus dimensions and less calcified valves were preferentially treated with ACURATE neo\/ACURATE neo2 SEV. In-hospital Valve Academic Research Consortium-3 endpoints and 1-year mortality were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      ACURATE was used in 182 (30%) patients and SAPIEN 3 in 425 (70%) patients. The proportion of women was higher in the ACURATE group (65% vs. 31%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), and patients were older (84 vs. 80\u2005years,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). Technical success (97% vs. 97%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;gt;\u20090.99) and new permanent pacemaker implantation during index hospitalisation (10% vs. 10%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;gt;\u20090.99) did not differ between the ACURATE and SAPIEN 3 groups. Intended performance was higher in the ACURATE group than in the SAPIEN 3 group (98% vs. 91%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005), with aortic regurgitation \u2265moderate (2% vs. &amp;lt;1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.32), and mean transvalvular gradient \u226520\u2005mmHg (&amp;lt;1% vs. 4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.043). The estimated mortality at 1\u2005year was 14% versus 12% (log-rank\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.60) in the ACURATE and SAPIEN 3 groups, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A prospective device selection strategy using two complementary TAVI valves resulted in comparable outcomes between the SEV and BEV devices. In-hospital intended performance was higher in the ACURATE group. Despite baseline group differences, there was no difference in 1-year mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1710186","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:47:07Z","timestamp":1779889627000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Partner valves: role of a prospective device selection strategy using ACURATE and SAPIEN 3 as complementary devices in transcatheter aortic valve implantation"],"prefix":"10.3389","volume":"13","author":[{"given":"Jonathan M.","family":"Michel","sequence":"first","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neria E.","family":"Winkler","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]},{"name":"Faculty of Medicine, University of Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Theil","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Kleeberger","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Schweiger","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charit\u00e9 (DHZC)","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Candreva","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gotschy","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Stehli","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Haubner","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry G.","family":"Donati","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Kowalik","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Medical University of Gdansk","place":["Gda\u0144sk, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dijana","family":"Savic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Templin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Greifswald University Hospital","place":["Greifswald, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara E.","family":"St\u00e4hli","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]},{"name":"Faculty of Medicine, University of Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix C.","family":"Tanner","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]},{"name":"Faculty of Medicine, University of Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gilhofer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Winterthur Hospital","place":["Winterthur, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert M.","family":"Kasel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.jacc.2016.11.033","article-title":"2016 Annual report of the Society of Thoracic Surgeons\/American College of Cardiology transcatheter valve therapy registry","volume":"69","author":"Grover","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e012294","DOI":"10.1161\/CIRCINTERVENTIONS.122.012294","article-title":"Real-world multiple comparison of transcatheter aortic valves: insights from the multicenter OBSERVANT II study","volume":"15","author":"Costa","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"B3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.15420\/icr.2018.20.2","article-title":"Annular rupture during transcatheter aortic valve implantation: predictors, management and outcomes","volume":"13","author":"Coughlan","year":"2018","journal-title":"Interv Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJMoa2312573","article-title":"Self-expanding or balloon-expandable TAVR in patients with a small aortic annulus","volume":"390","author":"Herrmann","year":"2024","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/S0140-6736(19)32220-2","article-title":"Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial","volume":"394","author":"Lanz","year":"2019","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1161\/CIRCULATIONAHA.120.051547","article-title":"Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: SCOPE 2 randomized clinical trial","volume":"142","author":"Tamburino","year":"2020","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/S0140-6736(25)00319-8","article-title":"ACURATE Neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial","volume":"405","author":"Makkar","year":"2025","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jcin.2024.09.042","article-title":"1-year outcomes of transcatheter aortic valve replacement using a self-expanding vs balloon-expandable transcatheter aortic valve","volume":"18","author":"Kim","year":"2025","journal-title":"J Am Coll Cardiol Intv"},{"key":"B11","year":"2025"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s00392-021-01935-7","article-title":"Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves","volume":"110","author":"Michel","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"77","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.amjcard.2019.07.028","article-title":"Meta-analysis comparing transcatheter aortic valve implantation with balloon versus self-expandable valves","volume":"124","author":"Osman","year":"2019","journal-title":"Am J Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12872-023-03397-3","article-title":"Comparison of outcomes of self-expanding versus balloon-expandable valves for transcatheter aortic valve replacement: a meta-analysis of randomized and propensity-matched studies","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11936-018-0651-x","article-title":"Sex-specific considerations in women with aortic stenosis and outcomes after transcatheter aortic valve replacement","volume":"20","author":"Mihos","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.jacc.2013.01.047","article-title":"Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature","volume":"61","author":"Athappan","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e012873","DOI":"10.1161\/CIRCINTERVENTIONS.123.012873","article-title":"Final 3-year outcomes of a randomized trial comparing a self-expanding to a balloon-expandable transcatheter aortic valve","volume":"16","author":"Lanz","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"B19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4244\/EIJ-D-22-00164","article-title":"ACURATE Neo2 versus SAPIEN 3 ultra for transcatheter aortic valve implantation","volume":"18","author":"Pellegrini","year":"2023","journal-title":"EuroIntervention"},{"key":"B20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.recesp.2018.05.042","article-title":"Multicenter evaluation of prosthesis oversizing of the SAPIEN 3 transcatheter heart valve. Impact on device failure and new pacemaker implantations","volume":"72","author":"Pellegrini","year":"2019","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.amjcard.2024.08.013","article-title":"Five-year outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve implantation","volume":"231","author":"Al-Azizi","year":"2024","journal-title":"Am J Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jcin.2022.11.032","article-title":"5-year outcomes with self-expanding vs balloon-expandable transcatheter aortic valve replacement in patients with small annuli","volume":"16","author":"Okuno","year":"2023","journal-title":"J Am Coll Cardiol Intv"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1710186\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:47:08Z","timestamp":1779889628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1710186\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":22,"alternative-id":["10.3389\/fcvm.2026.1710186"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1710186","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"article-number":"1710186"}}